Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
TKNO

TKNO - Alpha Teknova, Inc. Stock Price, Fair Value and News

1.91USD-0.01 (-0.52%)Delayed as of 08 May 2024, 12:59 pm ET

Market Summary

TKNO
USD1.91-0.01
Delayedas of 08 May 2024, 12:59 pm
-0.52%

TKNO Stock Price

View Fullscreen

TKNO RSI Chart

TKNO Valuation

Market Cap

78.4M

Price/Earnings (Trailing)

-2.13

Price/Sales (Trailing)

2.14

EV/EBITDA

-1.96

Price/Free Cashflow

-2.93

TKNO Price/Sales (Trailing)

TKNO Profitability

EBT Margin

-101.07%

Return on Equity

-40.85%

Return on Assets

-28.6%

Free Cashflow Yield

-34.13%

TKNO Fundamentals

TKNO Revenue

Revenue (TTM)

36.7M

Rev. Growth (Yr)

-0.3%

Rev. Growth (Qtr)

-3.7%

TKNO Earnings

Earnings (TTM)

-36.8M

Earnings Growth (Yr)

19.84%

Earnings Growth (Qtr)

-4.95%

Breaking Down TKNO Revenue

52 Week Range

1.624.27
(Low)(High)

Last 7 days

9.8%

Last 30 days

-24%

Last 90 days

-43.1%

Trailing 12 Months

4.4%

How does TKNO drawdown profile look like?

TKNO Financial Health

Current Ratio

5.14

Debt/Equity

0.15

Debt/Cashflow

-1.42

TKNO Investor Care

Shares Dilution (1Y)

44.78%

Diluted EPS (TTM)

-1.16

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202339.4M39.2M36.7M36.7M
202239.0M42.3M43.6M41.4M
202132.7M34.1M35.5M36.9M
202000031.3M

Tracking the Latest Insider Buys and Sells of Alpha Teknova, Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Nov 30, 2023
gelhaus ken
bought
6,219
1.734
3,587
chief commercial officer
Nov 14, 2023
hood lisa
sold
-
-
-15,000
chief people officer
Sep 19, 2023
mackowski j matthew
bought
1,500,000
1.85
810,810
-
Sep 19, 2023
telegraph hill partners iv, l.p.
bought
2,202,000
1.85
1,190,270
-
Sep 19, 2023
telegraph hill partners iv, l.p.
bought
12,798,000
1.85
6,917,840
-
Sep 19, 2023
terrill damon
bought
49,999
1.85
27,027
general counsel and cco
Sep 19, 2023
gunstream stephen
bought
99,999
1.85
54,054
president and ceo
Sep 19, 2023
lowell matthew
bought
99,999
1.85
54,054
chief financial officer
Aug 31, 2023
mcnamara robert
back to issuer
-
-
-18,815
-
Jun 13, 2023
hood lisa
sold
-43,267
3.7954
-11,400
chief people officer

1–10 of 47

Which funds bought or sold TKNO recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 01, 2024
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
sold off
-
-
-
-%
Apr 26, 2024
Conestoga Capital Advisors, LLC
added
0.98
-260,918
662,365
0.01%
Apr 25, 2024
Fielder Capital Group LLC
unchanged
-
-45,197
110,900
0.05%
Apr 24, 2024
BROWN ADVISORY INC
unchanged
-
-12,024
29,502
-%
Mar 11, 2024
VANGUARD GROUP INC
reduced
-2.00
348,192
1,470,830
-%
Feb 15, 2024
JANE STREET GROUP, LLC
new
-
38,911
38,911
-%
Feb 14, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC
unchanged
-
65,800
261,100
0.01%
Feb 14, 2024
Balyasny Asset Management L.P.
reduced
-1.95
924,888
3,900,340
0.01%
Feb 14, 2024
MILLENNIUM MANAGEMENT LLC
added
2.6
1,830,030
6,753,180
-%

1–10 of 38

Are Funds Buying or Selling TKNO?

Are funds buying TKNO calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own TKNO
No. of Funds

Unveiling Alpha Teknova, Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
telegraph hill partners iv, l.p.
62.9%
25,620,792
SC 13G/A
Oct 06, 2023
telegraph hill partners iv, l.p.
62.9%
25,620,792
SC 13G/A
Feb 14, 2022
davis ted
-
0
SC 13G
Feb 14, 2022
telegraph hill partners iv, l.p.
62.5%
17,512,685
SC 13G

Recent SEC filings of Alpha Teknova, Inc.

View All Filings
Date Filed Form Type Document
Apr 29, 2024
DEFA14A
DEFA14A
Apr 29, 2024
DEF 14A
DEF 14A
Apr 29, 2024
ARS
ARS
Apr 02, 2024
8-K
Current Report
Mar 27, 2024
S-8
Employee Benefits Plan
Mar 27, 2024
10-K
Annual Report
Mar 11, 2024
8-K
Current Report
Feb 27, 2024
4
Insider Trading
Feb 22, 2024
DEF 14C
DEF 14C
Feb 14, 2024
SC 13G/A
Major Ownership Report

Peers (Alternatives to Alpha Teknova, Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
357.8B
85.6B
-2.43% -8.39%
9.3
4.18
5.68% 202.39%
330.2B
61.4B
1.86% 10.13%
143.19
5.38
6.11% -82.30%
161.1B
29.5B
11.28% 28.04%
42.82
5.46
12.76% -52.47%
156.8B
46.5B
4.16% -28.19%
-112.94
3.37
42.59% -114.62%
81.5B
27.1B
-5.96% -16.75%
14.39
3.01
-0.60% 23.36%
15.6B
15.8B
-2.04% 54.08%
-27.14
0.99
6.17% 76.47%
MID-CAP
4.2B
1.7B
-5.86% -20.45%
9.58
2.41
54.01% 364.56%
4.1B
4.6B
-3.95% -16.22%
-533.77
0.9
-0.06% 94.55%
2.7B
9.0B
-28.82% 23.71%
-5.97
0.3
10.01% -27.45%
2.1B
644.4M
2.42% 17.52%
14.96
3.19
29.14% 50.51%
SMALL-CAP
1.5B
743.2M
-23.46% -28.42%
-4.38
2.07
24.65% 80.36%
23.2M
1.3M
-9.05% -48.20%
-2.26
17.8
-98.14% -109.18%
17.0M
-
-15.25% 35.14%
-0.92
0.22
2882.68% -138.52%
2.7M
19.6M
31.03% -94.02%
-0.19
0.14
80.00% 43.08%
1.1M
117.6M
-57.29% -90.96%
0
0.01
-0.79% -283.60%

Alpha Teknova, Inc. News

Latest updates
MSN • 05 May 2024 • 09:19 am
CNN • 26 Mar 2024 • 01:33 pm
Financial Content • 5 months ago

Alpha Teknova, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q2
Revenue-3.7%7,867,0008,169,00011,527,0009,121,0007,891,00010,692,00011,690,00011,147,00010,110,0009,392,0008,313,0009,078,0009,031,0008,984,0006,044,000
Gross Profit-9.3%1,335,0001,472,0005,066,0002,423,0002,110,0004,770,0005,247,0005,349,0004,979,0004,263,0003,354,0005,025,000-5,088,0003,469,000
Operating Expenses19.1%12,193,00010,234,00012,063,00011,369,00016,346,00027,724,00011,873,00011,192,0009,745,5008,151,0005,880,0005,853,000-2,936,0002,765,000
  S&GA Expenses-0.5%2,401,0002,412,0002,174,0002,343,0002,559,0002,397,0002,598,0001,597,0001,283,000885,000904,000705,000-558,000481,000
  R&D Expenses-6.2%1,311,0001,397,0001,464,0001,395,0001,870,0001,925,0001,929,0002,013,0001,389,5001,372,000851,000700,000-358,000341,000
EBITDA Margin10.7%-0.88-0.98-1.25-1.23-1.11-0.85-0.44-0.39-0.280.190.200.210.22--
Interest Expenses121.9%173,000-791,000-308,00093,000128,00070,00028,000-13,000-36,500-255,000-304,0007,000-19,000-
Income Taxes-3477.8%-304,0009,00015,000-18,000-786,000-374,000-400,000-400,000-1,205,500-892,000-600,000-165,000-636,000200,000
Earnings Before Taxes-8.0%-10,960,000-10,144,000-7,139,000-8,835,000-14,089,000-22,848,000-6,598,000-5,856,000-4,841,000-4,143,000-2,833,000-820,000-2,169,000723,000
EBT Margin7.7%-1.01-1.10-1.35-1.33-1.19-0.92-0.51-0.45-0.340.130.140.140.15--
Net Income-5.0%-10,656,000-10,153,000-7,154,000-8,817,000-13,294,000-22,474,000-6,203,000-5,497,000-3,647,000-3,251,000-2,250,000-655,000-1,533,000512,000
Net Income Margin6.6%-1.00-1.07-1.32-1.29-1.15-0.87-0.44-0.38-0.270.100.100.110.11--
Free Cashflow40.2%-3,204,000-5,354,000-6,194,000-11,996,000-12,759,000-14,914,000-16,758,000-11,118,000-10,494,000-8,744,000-8,225,000-1,483,000---
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22020Q4
Assets-7.1%12913813314115216018218416716917363.00
  Current Assets-10.6%46.0051.0043.0050.0061.0070.0080.0092.0010111111816.00
    Cash Equivalents-11.2%29.0032.0024.0030.0042.0050.0065.0076.0088.0098.001083.00
  Inventory1.1%12.0011.0012.0012.0012.0010.008.006.005.004.004.004.00
  Net PPE-2.4%50.0052.0053.0054.0052.0053.0047.0037.0030.0022.0018.0010.00
  Goodwill-------17.0017.0017.0017.0017.0017.00
Liabilities-0.5%39.0039.0046.0049.0052.0048.0049.0046.0023.0023.0024.0011.00
  Current Liabilities6.4%9.008.0029.009.0011.0012.0012.0013.008.006.006.004.00
  Long Term Debt0.6%13.0013.00-22.0022.0017.0017.0012.0012.0012.0012.00-
    LT Debt, Current---22.00---------
    LT Debt, Non Current-100.0%-13.00--22.00-------
Shareholder's Equity-9.6%90.0010086.0092.0010011213313914314614917.00
  Retained Earnings-13.2%-91.79-81.10-70.98-63.82-55.01-41.71-19.24-13.03-7.54-3.89-0.642.00
  Additional Paid-In Capital0.6%18218115715615515415315215115015014.00
Shares Outstanding0.2%41.0041.0028.0028.0028.0028.0028.0028.0028.0012.004.004.00
Float---19.00---59.00---164-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q2
Cashflow From Operations34.0%-2,892-4,382-3,856-7,684-8,029-8,332-5,838-5,201-3,082-4,837-3,5512,401---
  Share Based Compensation-1.3%1,0221,0351,0701,0101,022968934787624442302183---
Cashflow From Investing88.2%-115-972-2,338-4,312-4,730-6,582-10,920-5,917-7,412-3,907-4,674-1,528---
Cashflow From Financing-104.6%-62113,625-180-25.005,14035.005,03755.00-1.00-1,265101,78110,278---
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

TKNO Income Statement

2023-12-31
Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]  
Revenue$ 36,684$ 41,420
Cost of sales26,38823,944
Gross profit10,29617,476
Operating expenses:  
Research and development5,5677,737
Sales and marketing9,3309,151
General and administrative25,45028,298
Amortization of intangible assets1,1481,148
Goodwill impairment016,613
Tradename impairment2,1690
Long-lived assets impairment2,1954,188
Total operating expenses45,85967,135
Loss from operations(35,563)(49,659)
Other (expenses) income, net  
Interest (expense) income, net(833)213
Other income, net14255
Loss on extinguishment of debt(824)0
Total other (expenses) income, net(1,515)268
Loss before income taxes(37,078)(49,391)
Benefit from income taxes(298)(1,923)
Net loss$ (36,780)$ (47,468)
Earnings Per Share [Abstract]  
Basic$ (1.16)$ (1.69)
Diluted$ (1.16)$ (1.69)
Weighted Average Number of Shares Outstanding, Basic and Diluted [Abstract]  
Basic31,819,77628,083,563
Diluted31,819,77628,083,563

TKNO Balance Sheet

2023-12-31
Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 28,484$ 42,236
Accounts receivable, net of allowance for doubtful accounts of $20 thousand and $22 thousand3,9484,261
Inventories, net11,59412,247
Income taxes receivable022
Prepaid expenses and other current assets1,6342,374
Total current assets45,66061,140
Property, plant and equipment, net50,36451,577
Operating lease right-of-use assets16,47219,736
Intangible assets, net14,23917,556
Other non-current assets1,8522,252
Total assets128,587152,261
Current liabilities:  
Accounts payable1,4932,449
Accrued liabilities5,5796,203
Current portion of operating lease liabilities1,8032,223
Total current liabilities8,87510,875
Deferred tax liabilities9191,223
Other accrued liabilities102191
Long-term debt13,25121,976
Long-term operating lease liabilities15,40418,111
Total liabilities38,55152,376
Stockholders’ equity:  
Preferred stock, $0.00001 par value, 10,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively, zero shares issued and outstanding at December 31, 2023 and December 31, 202200
Common stock, $0.00001 par value, 490,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively, 40,727,780 and 28,179,423 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively00
Additional paid-in capital181,822154,891
Accumulated deficit(91,786)(55,006)
Total stockholders’ equity90,03699,885
Total liabilities and stockholders equity$ 128,587$ 152,261
TKNO
Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
 CEO
 WEBSITEteknova.com
 INDUSTRYPharmaceuticals
 EMPLOYEES285

Alpha Teknova, Inc. Frequently Asked Questions


What is the ticker symbol for Alpha Teknova, Inc.? What does TKNO stand for in stocks?

TKNO is the stock ticker symbol of Alpha Teknova, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Alpha Teknova, Inc. (TKNO)?

As of Tue May 07 2024, market cap of Alpha Teknova, Inc. is 78.38 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TKNO stock?

You can check TKNO's fair value in chart for subscribers.

What is the fair value of TKNO stock?

You can check TKNO's fair value in chart for subscribers. The fair value of Alpha Teknova, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Alpha Teknova, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for TKNO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Alpha Teknova, Inc. a good stock to buy?

The fair value guage provides a quick view whether TKNO is over valued or under valued. Whether Alpha Teknova, Inc. is cheap or expensive depends on the assumptions which impact Alpha Teknova, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TKNO.

What is Alpha Teknova, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 07 2024, TKNO's PE ratio (Price to Earnings) is -2.13 and Price to Sales (PS) ratio is 2.14. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TKNO PE ratio will change depending on the future growth rate expectations of investors.